UNODC: CND decision on international control of Butonitazene enters into force in June 2024
VIENNA, Austria – June 2024: The decision adopted by the Commission on Narcotic Drugs (CND) during its 67th regular session from 18 to 22 March 2024 to add Butonitazene to Schedule I of the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, was communicated by the Secretary-General on 6 June 2024 to all Members States of the United Nations, to non-member States Parties to the Conventions, to the World Health Organization and to the International Narcotics Control Board and thereby entered into force on the date of receipt of the notification for each party.
The decision adopted by the CND to add 3-chloromethcathinone (3-CMC), Dipentylone and 2-fluorodeschloroketamine to Schedule II and Bromazolam to Schedule IV of the Convention on Psychotropic Substances of 1971 will come into force on 3 December 2024.
For further information please see:
EWA News: April 2024 – UNODC: First reported NPS in 2023 show strong increase in synthetic opioids as stimulants and synthetic cannabinoids diversify (www.unodc.org/LSS/Announcement/Details/89a02deb-3344-4308-9980-ca4ca4dc8671)
EWA News: March 2024 – UNODC: Five NPS “scheduled” at the 67th Session of the Commission on Narcotic Drugs (www.unodc.org/LSS/Announcement/Details/1b87807d-09de-4a33-8fdd-10875f5750d3)
EWA News:February 2024 – UNODC EWA: Nitazenes – a new group of synthetic opioids emerges (www.unodc.org/LSS/Announcement/Details/cbec8f4c-73aa-49ee-9e2b-75620af8a910)
EWA News: December 2023 – WHO: World Health Organization recommends five NPS for scheduling (www.unodc.org/LSS/Announcement/Details/93c6537d-52c7-49b8-aaf6-2673203de9cd)
